Failure-to-Warn Claim Targeting Branded Drug Held Preempted: Litigation-Driven Expert Analysis Is Not Newly Acquired Information for Purposes of the Changes Being Effected Regulation

Under Wyeth v. Levine, 555 U.S. 555 (2009), and PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011), failure-to-warn claims targeting a pharmaceutical are…

Related Keywords

,Merck Co Inc ,Pfizer Inc ,Merck Co ,Pliva Inc ,Under Wyeth ,Incretin Based Therapies ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Sa ,Litigation ,